Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Bayer plc, 400 South Oak Way, Reading, RG2 6AD
Gastrografin gastroenteral solution.
| Pharmaceutical Form |
|---|
|
Gastroenteral solution. |
1 ml solution contains: 100 mg sodium amidotrizoate (sodium diatrizoate) and 660 mg meglumine amidotrizoate (meglumine diatrizoate).
Excipients with known effect: Gastografin contains sodium, see section 4.4.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Diatrizoic acid |
|
|
| Meglumine |
|
| List of Excipients |
|---|
|
Disodium edetate |
Packs of 10 × 100 ml brown glass bottles with pilfer proof screw caps.
Bayer plc, 400 South Oak Way, Reading, RG2 6AD
PL 00010/0537
Date of First Authorisation: 01 May 2008
| Drug | Countries | |
|---|---|---|
| GASTROGRAFIN | Canada, Cyprus, Spain, Finland, Hong Kong, Croatia, Ireland, Japan, Malta, New Zealand, Poland, Singapore, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
